Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Test-treatment RCTs are susceptible to bias: a review of the methodological quality of randomized trials that evaluate diagnostic tests.

Ferrante di Ruffano L, Dinnes J, Sitch AJ, Hyde C, Deeks JJ.

BMC Med Res Methodol. 2017 Feb 24;17(1):35. doi: 10.1186/s12874-016-0287-z.

2.

Research waste in diagnostic trials: a methods review evaluating the reporting of test-treatment interventions.

Ferrante di Ruffano L, Dinnes J, Taylor-Phillips S, Davenport C, Hyde C, Deeks JJ.

BMC Med Res Methodol. 2017 Feb 24;17(1):32. doi: 10.1186/s12874-016-0286-0.

3.

Statistical controversies in clinical research: prognostic gene signatures are not (yet) useful in clinical practice.

Michiels S, Ternès N, Rotolo F.

Ann Oncol. 2016 Dec;27(12):2160-2167. doi: 10.1093/annonc/mdw307. Review.

4.

Methodologic approaches to evaluating new highly sensitive diagnostic tests: avoiding overdiagnosis.

de Groot JA, Naaktgeboren CA, Reitsma JB, Moons KG.

CMAJ. 2016 Jul 4. pii: cmaj.150999. [Epub ahead of print] No abstract available.

PMID:
27378465
5.

Recommendations for a step-wise comparative approach to the evaluation of new screening tests for colorectal cancer.

Young GP, Senore C, Mandel JS, Allison JE, Atkin WS, Benamouzig R, Bossuyt PM, Silva MD, Guittet L, Halloran SP, Haug U, Hoff G, Itzkowitz SH, Leja M, Levin B, Meijer GA, O'Morain CA, Parry S, Rabeneck L, Rozen P, Saito H, Schoen RE, Seaman HE, Steele RJ, Sung JJ, Winawer SJ.

Cancer. 2016 Mar 15;122(6):826-39. doi: 10.1002/cncr.29865.

6.

Impact of GeneXpert MTB/RIF assay on triage of respiratory isolation rooms for inpatients with presumed tuberculosis: a hypothetical trial.

Chaisson LH, Roemer M, Cantu D, Haller B, Millman AJ, Cattamanchi A, Davis JL.

Clin Infect Dis. 2014 Nov 15;59(10):1353-60. doi: 10.1093/cid/ciu620.

7.

Impact of GeneXpert MTB/RIF on patients and tuberculosis programs in a low-burden setting. a hypothetical trial.

Davis JL, Kawamura LM, Chaisson LH, Grinsdale J, Benhammou J, Ho C, Babst A, Banouvong H, Metcalfe JZ, Pandori M, Hopewell PC, Cattamanchi A.

Am J Respir Crit Care Med. 2014 Jun 15;189(12):1551-9. doi: 10.1164/rccm.201311-1974OC.

8.

From accuracy to patient outcome and cost-effectiveness evaluations of diagnostic tests and biomarkers: an exemplary modelling study.

Koffijberg H, van Zaane B, Moons KG.

BMC Med Res Methodol. 2013 Jan 31;13:12. doi: 10.1186/1471-2288-13-12.

9.

Efficiency of study designs in diagnostic randomized clinical trials.

Lu B, Gatsonis C.

Stat Med. 2013 Apr 30;32(9):1451-66. doi: 10.1002/sim.5655.

10.

Accuracy of single progesterone test to predict early pregnancy outcome in women with pain or bleeding: meta-analysis of cohort studies.

Verhaegen J, Gallos ID, van Mello NM, Abdel-Aziz M, Takwoingi Y, Harb H, Deeks JJ, Mol BW, Coomarasamy A.

BMJ. 2012 Sep 27;345:e6077. doi: 10.1136/bmj.e6077. Review.

11.

Diagnostic randomized controlled trials: the final frontier.

Rodger M, Ramsay T, Fergusson D.

Trials. 2012 Aug 16;13:137. doi: 10.1186/1745-6215-13-137.

12.

Chapter 1: Introduction to the Methods Guide for Medical Test Reviews.

Matchar DB.

J Gen Intern Med. 2012 Jun;27 Suppl 1:S4-10. doi: 10.1007/s11606-011-1798-2.

13.

Using patient management as a surrogate for patient health outcomes in diagnostic test evaluation.

Staub LP, Lord SJ, Simes RJ, Dyer S, Houssami N, Chen RY, Irwig L.

BMC Med Res Methodol. 2012 Feb 14;12:12. doi: 10.1186/1471-2288-12-12.

14.

Evaluation of tuberculosis diagnostics: establishing an evidence base around the public health impact.

Lessells RJ, Cooke GS, Newell ML, Godfrey-Faussett P.

J Infect Dis. 2011 Nov 15;204 Suppl 4:S1187-95. doi: 10.1093/infdis/jir412. Review.

15.

The promise and realities of comparative effectiveness research.

Gatsonis C.

Stat Med. 2010 Aug 30;29(19):1977-81; discussion 1996-7. doi: 10.1002/sim.3936.

16.

Does point of care prothrombin time measurement reduce the transfusion of fresh frozen plasma in patients undergoing major surgery? The POC-OP randomized-controlled trial.

Urwyler N, Trelle S, Theiler L, Jüni P, Staub LP, Luyet C, Alberio L, Stricker K, Greif R.

Trials. 2009 Nov 23;10:107. doi: 10.1186/1745-6215-10-107.

17.

Mediastinal staging of NSCLC with endoscopic and endobronchial ultrasound.

Navani N, Spiro SG, Janes SM.

Nat Rev Clin Oncol. 2009 May;6(5):278-86. doi: 10.1038/nrclinonc.2009.39. Review.

18.

Grading quality of evidence and strength of recommendations for diagnostic tests and strategies.

Schünemann HJ, Oxman AD, Brozek J, Glasziou P, Jaeschke R, Vist GE, Williams JW Jr, Kunz R, Craig J, Montori VM, Bossuyt P, Guyatt GH; GRADE Working Group..

BMJ. 2008 May 17;336(7653):1106-10. doi: 10.1136/bmj.39500.677199.AE. No abstract available. Erratum in: BMJ. 2008 May 24;336(7654). doi: 10.1136/bmj.a139. Schünemann, A Holger J [corrected to Schünemann, Holger J].

19.

A randomised clinical trial on cardiotocography plus fetal blood sampling versus cardiotocography plus ST-analysis of the fetal electrocardiogram (STAN) for intrapartum monitoring.

Westerhuis ME, Moons KG, van Beek E, Bijvoet SM, Drogtrop AP, van Geijn HP, van Lith JM, Mol BW, Nijhuis JG, Oei SG, Porath MM, Rijnders RJ, Schuitemaker NW, van der Tweel I, Visser GH, Willekes C, Kwee A.

BMC Pregnancy Childbirth. 2007 Jul 26;7:13.

20.

Comparative accuracy: assessing new tests against existing diagnostic pathways.

Bossuyt PM, Irwig L, Craig J, Glasziou P.

BMJ. 2006 May 6;332(7549):1089-92. Review. No abstract available. Erratum in: BMJ. 2006 Jun 10;332(7554):1368.

Supplemental Content

Support Center